Medium1/3 relationships sourcedProfile verified Aug 14, 2026

30-Second Executive Brief

Executive Assessment

Biograph functions as a regional institution within Healthcare & Life Sciences, backed by 17% sourcing coverage, though its relative influence is cooling.

  • Maintains 3 mapped relationships across the graph
  • 17% sourcing coverage across sourced relationships
  • Tracked as regional institution within the Healthcare & Life Sciences category

Executive Snapshot

Strategic Role
Regional Institution
Sourcing Coverage
17%
View Methodology →

Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.

Ecosystem Influence
Moderate
Strategic Momentum
Decelerating

Coverage

Mapped Relationships
3
Technology Domains
5

Strategic Implications

  • Central node connecting multiple strategic ecosystems
  • Directly influences technology and capital flows
  • Material relevance to downstream dependency mapping

Top Opportunities

Planned international expansion beyond its initial New York and San Francisco clinics.

Top Risks

Premium, clinic-based pricing model limits addressable market compared to lower-cost at-home testing competitors.

Critical Dependencies

Continue to Dependency Graph ↓

A preventive-health and longevity-diagnostics clinic co-founded by Peter Attia, MD (author of Outlive), that launched in February 2025 with clinics in New York and San Francisco. Biograph collects over 1,000 data points across 30-plus evaluations spanning five health pillars — atherosclerotic cardiovascular disease, metabolic dysfunction, brain health, cancer risk, and quality-of-life metrics — and has raised $53.9M from investors including Alpha Wave Global, WndrCo, Human Capital, and Wellness Holding. In May 2026 it launched an executive-health offering combining imaging, biomarkers, and physician-led insights.

Sources

Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.

Evidence

2 sources

  • Health Club ManagementPeter Attia-backed Biograph shares plans to expand internationallynews
  • Business WireBiograph launches as advanced preventive health and diagnostics clinicnews

Acquisition & Investment Fit

AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.

Relationship Map

The relationships surrounding Biograph — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.

Connection type

Sign in free to click a node and explore →

Click any node to make it the new center. Scroll to zoom, drag to pan.

The Story So Far (last 6 months)

May 2026: Launched executive-health offeringAug 2026: Biograph's Peter Attia founder brand is likely doing more commercial work than its clinic… (unconfirmed)

Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.

Market Intelligence

Unverified

Credibly-reported claims — analyst notes, sourcing citing “people familiar with the matter,” deals where the companies involved declined to comment — that haven't been officially confirmed. Kept structurally separate from the sourced evidence above; treat as a lead worth researching further, not an established fact.

Biograph's Peter Attia founder brand is likely doing more commercial work than its clinical differentiation

31% confidence

Biograph, co-founded by Peter Attia (author of the bestselling longevity book Outlive), launched with clinics in New York and San Francisco and raised $53.9M, competing directly with Function Health and Fountain Life on largely similar data-point and biomarker panels.

This is InsightNodes' own interpretive read: the underlying diagnostic offerings across premium longevity clinics (Biograph, Fountain Life, Function Health) are converging on similar data-point counts and evaluation categories, meaning founder credibility and brand trust -- particularly Attia's large, engaged following from Outlive -- may be doing more to drive customer acquisition than any clinical differentiation, a dynamic worth watching as the category matures and clinical outcomes data becomes more available to compare providers on substance rather than brand alone.

InsightNodes analysis of Biograph positioning · Aug 14, 2026

Biograph's Timeline

A sourced, dated history of Biograph's key moments — founding to present.

  1. Feb 2025 · Launched with New York and San Francisco clinics

    Biograph launched publicly as a preventive-health and diagnostics clinic co-founded by Peter Attia, opening locations in New York and San Francisco.

  2. May 2026 · Launched executive-health offering

    Biograph introduced an offering combining imaging, biomarkers, and physician-led insights aimed at executives and organizations.